It ain’t over yet: HK ECM faces hurdles before year end

Hong Kong equity investors may feel they need a break after a year of underperforming IPOs, sharp declines in valuations and protracted volatility. But don’t call time on the market just yet.

  • By Jonathan Breen
  • 30 Oct 2018
Email a colleague
Request a PDF

Hong Kong’s market has been hectic this year, driven in large part by the stock exchange’s long-awaited decision in April to amend its rules to allow technology companies to float dual-class shares, as well as paving the way for listings by pre-revenue biotechnology firms. A pipeline quickly blossomed for both, but the second half of 2018 turned into a mess as stock after stock tanked.

The shocking global rout in equity markets in October has added insult to injury and consequently many bankers are predicting that most of the buyside is likely to go into hibernation for the rest of the year. But a small group of bankers will be praying the gates are not closed just yet. There are still deals to get done.

Four mainland firms — Babytree Group, Mobvista, Tongcheng-Elong Holdings and Wanka Online — believe they can make it next month, bringing $3bn of IPOs between them. Hong Kong investors will need to hold their nerve a little longer.

Why exactly are these companies pushing ahead with Hong Kong IPOs after a flood of tech listings that have almost all fallen underwater in the aftermarket? Some of the biggest and most disappointing IPOs this year include those by smartphone maker Xiaomi and food delivery start-up Meituan Dianping, which raised HK$37.1bn ($4.7bn) in July and HK$33.1bn in September, respectively. But both stocks have since tumbled more than 30%.

The answer to that question appears to be simple: the money is still there. Despite the barrage of volatility, telecom, media and technology deals have continued to get done. Investors, retail and institutional alike, still appear to be mesmerised by the relative scarcity value of new economy companies. The supply of IPOs in large part petered out in early October, but even last week Chinese biotech firm Innovent Biologics was able to get away with HK$3.3bn, pricing just below the top of guidance.

So, although it is clearly brave, it seems more than just a gamble to bank on there being some remaining demand from investors. There is a real chance that at least some of the quartet will get their deals away. The end of this year will say a lot about the appetite of investors — and their willingness to keep diving in to a volatile market.

  • By Jonathan Breen
  • 30 Oct 2018

Panda Bonds Top Arrangers

Rank Arranger Share % by Volume
1 China Merchants Securities Co 15.31
2 Industrial and Commercial Bank of China (ICBC) 12.35
3 CITIC Securities 8.92
4 Agricultural Bank of China (ABC) 7.60
5 China CITIC Bank Corp 6.76

Bookrunners of Asia-Pac (ex-Japan) ECM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Goldman Sachs 17,772.74 86 7.60%
2 Morgan Stanley 14,624.46 73 6.25%
3 Citi 14,439.29 99 6.17%
4 UBS 13,054.43 87 5.58%
5 China International Capital Corp Ltd 11,814.82 50 5.05%

Bookrunners of Asia Pacific (ex-Japan) G3 DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 26,480.74 228 7.82%
2 Citi 23,876.05 159 7.05%
3 JPMorgan 15,475.44 97 4.57%
4 Goldman Sachs 13,893.80 68 4.10%
5 Bank of America Merrill Lynch 13,756.20 87 4.06%

Asian polls & awards

  • GlobalCapital Asia capital markets awards 2018: Investment banks

    In the fourth and final instalment of GlobalCapital Asia’s capital markets awards announcements, find out the Best Asian Investment Bank and the Best Investment Bank in the region for 2018.

  • GlobalCapital Asia capital markets awards 2018: Bonds

    In part three of our results announcements, we reveal the winning bond deals across a variety of categories. In addition, we also name the Best G3 Bond House, Best Local Currency Bond House, Best High Yield Bond House and the debut winner of the Best House for SRI Financing.

  • GlobalCapital Asia capital markets awards 2018: Equities

    In part two of our results announcements, we reveal the winning equity deals and banks, including the Best Follow-on/Accelerated Bookbuild, Best Equity-Linked Deal, Best IPO, Best ECM Deal and Best ECM House.

  • GlobalCapital Asia capital markets awards 2018: Loans

    GlobalCapital Asia has spent the last two months talking to banks and their clients in a bid to determine the most impressive capital markets transactions and advisers across Asia ex-Japan in 2018. We are pleased to begin our awards announcements in the loan market.

  • GlobalRMB awards: Most impressive issuers, best law firm

    In this third part of the GlobalRMB awards, we present our reasons for choosing the best issuers in the FIG, corporate and SSA categories — and praise the strong performance of one well-known foreign law firm.